The Good, the Bad and the Ugly

BFD | 16 Dec 2021 Over the years I have met, had lunch, dinner, drinks or meetings with a vast number of politicians. Some were great, most were average, but none, with one exception, were evil. I grew up in a political family. We had cabinet ministers and prime ministers over for dinner. My mother…

What the VAERS Data Tell Us About COVID Jab Safety

Mercola | 19 Dec 2021 STORY AT-A-GLANCE The U.S. Vaccine Adverse Event Reporting System (VAERS) is among the best adverse event data collection systems in the world, but it’s antiquated and difficult to use. Still, it’s a good way to detect safety signals that weren’t detected during premarket testing or clinical trials There are unmistakable,…

Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California

medRxiv | 25 Aug 2021 Abstract Associations between vaccine breakthrough cases and infection by SARS coronavirus 2 (SARS-CoV-2) variants have remained largely unexplored. Here we analyzed SARS-CoV-2 whole-genome sequences and viral loads from 1,373 persons with COVID-19 from the San Francisco Bay Area from February 1 to June 30, 2021, of which 125 (9.1%) were…

Mechanisms of SARS-CoV-2 Evolution Revealing Vaccine-Resistant Mutations in Europe and America

PubMed | 16 Dec 2021 Abstract The importance of understanding SARS-CoV-2 evolution cannot be overlooked. Recent studies confirm that natural selection is the dominating mechanism of SARS-CoV-2 evolution, which favors mutations that strengthen viral infectivity. Here, we demonstrate that vaccine-breakthrough or antibody-resistant mutations provide a new mechanism of viral evolution. Specifically, vaccine-resistant mutation Y449S in…

Referenced Data for Parents Concerning the Pfizer COVID-19 Vaccination for Children Aged 5 through 11 Years

Journal of American Physicians and Surgeons | Winter 2021 On Oct 29, 2021, the Food and Drug Association (FDA) extended its Emergency Use Authorization (EUA) for the PfizerBioNTech “vaccine” to be given to reduce serious COVID-19 infections in children aged 5 through 11 years. The FDA provided little evidence for its decision except for a…

Ivermectin prophylaxis used for COVID-19 reduces COVID-19 infection and mortality rates: A 220,517-subject, populational-level retrospective citywide.

Research Gate | Dec 2021 Background: Ivermectin has demonstrated different mechanisms of actions that could potentially protect from both COVID-19 infection and COVID-19-related comorbidities. Based on the existing literature and safety profile of ivermectin, a citywide program of prophylactic use of ivermectin for COVID-19 was implemented in Itajai, a Southern city in Brazil in the…

Stunning Covid data from Denmark

Alex Berenson | 18 Dec 2021 But not for the reason you’ve been told; the story is vaccine failure, not Omicron The Danes are now publishing extremely detailed daily data about Covid cases and hospitalizations – not just about Omicron, but all Covid variants. And, in news that will surprise precisely no one who has been alive…

Vaccines are very good… for the drug companies

Steve Kirsch | 18 Dec 2021 Take your vaccine like they tell you. Do not ask questions. Just follow orders. This one graphic shows everything you need to know. This is one of the reasons why nobody wants to talk to me. The graphic is from a paper which was published in April 24, 2017: Pilot…